Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Trinity Biotech Q4 Profit Rises

RELATED NEWS
Trade TRIB now with 
3/5/2012 1:09 PM ET

Trinity Biotech plc (TRIB: Quote) Monday reported fourth-quarter profit of $4.0 million or 18.4 cents per american depositary receipt, or ADR, rising from last year's $3.7 million or 16.6 cents per ADR.

Revenues for the quarter rose 4 percent to $20.0 million from $19.2 million last year due to higher HIV sales in Africa and USA. Point-of-care revenue increased 12.4 percent while clinical laboratory revenue rose 2.1 percent from last year.

Click here to receive FREE breaking news email alerts for Trinity Biotech plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Russian Foreign Minister Sergei Lavrov warned Wednesday that Moscow would retaliate strongly if its "interests" in Ukraine are attacked. He also criticized the Ukrainian administration for relaunching its so-called anti-terrorist operation in the east of the country a day earlier. Lavrov's remarks came in an interview with Russia Today, which published excerpts of the English-language interview to While selling pressure has remained relatively subdued, stocks continue to see modest weakness in mid-day trading on Wednesday. The losses on the day come on the heels of the upward trend seen over the past several sessions. The major averages have moved roughly sideways in recent trading, lingering in the red. While a majority of Kentucky voters approve of the way Rand Paul is handling his job as Senator, the results of New York Times/Kaiser Family Foundation poll showed that voters from the Bluegrass State have a more mixed view on Paul's potential run for president in 2016.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.